12.07.2015 Views

A52-75-2007E.pdf - AgroMedia International Inc

A52-75-2007E.pdf - AgroMedia International Inc

A52-75-2007E.pdf - AgroMedia International Inc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Health38Prevention of fatty liver in transition dairy cows by subcutaneousinjections of glucagonCorresponding AuthorBeitz, D.C.Iowa State UniversityCollaboratorsNafikov, R.A.Iowa State UniversityAmetaj, B.N.University of AlbertaBobe, G.Iowa State UniversityKoehler, K.J.Iowa State UniversityYoung, J.W.Iowa State UniversityJournal of Dairy Science (2006) Vol. 89 p. 1533-1545.At or around calving, dairy cows are vulnerable to a number of metabolicdisorders, often related to accumulation of fat in the liver. Fatty liver (FL) isthe result of negative energy balance in early lactation—the energy demandfor milk production exceeds the animal’s ability to consume energy-yieldingnutrients. To satisfy energy demand, non-esterified fatty acids(NEFA) are mobilized from adipose (fat) tissues and are taken up by the liverwhere they may be oxidized, stored or exported. When storage exceedsoxidation or export, FL develops and ketosis may ensue. Glucagon is a proteinhormone that promotes an increase in blood glucose by increasingboth the rate of glycogen breakdown and the rate of glucose synthesis inthe liver. Previous work by these authors demonstrated that continuous14-day intravenous infusion of glucagon could be used to treat fatty liverin early lactation cows. The objective of the present trial was to determineif subcutaneous injections of glucagon could prevent FL. Cows were fedhigh energy diets in the last month of the dry period to increase their fatstores. At calving, they were assigned to one of 3 treatments: 7.5 mg/dayof glucagon in saline, 15 mg/day of glucagon in saline or saline alone (control).Injections were administered 3 times per day for 14 days starting at2 days after calving. The 15 mg/day glucagon treatment increased bloodglucose and insulin, decreased blood NEFA and prevented FL. Feed intake,milk production and milk composition were not affected.Health 83

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!